|
WO2000045849A2
(en)
*
|
1999-02-05 |
2000-08-10 |
Genzyme Corporation |
Use of cationic lipids to generate anti-tumor immunity
|
|
JP2003502350A
(ja)
*
|
1999-06-22 |
2003-01-21 |
リサーチ ディベロップメント ファンデーション |
傷癒合促進用促進傷被覆材
|
|
JP2003529550A
(ja)
*
|
1999-10-01 |
2003-10-07 |
リポクセン テクノロジーズ リミテッド |
リポソーム封入されたｄｎａ経口ワクチン
|
|
ATE274901T1
(de)
|
1999-12-13 |
2004-09-15 |
Lipoxen Technologies Ltd |
Liposomen enthaltend einen komplex aus polyanion und calciumphosphat
|
|
US6372250B1
(en)
*
|
2000-04-25 |
2002-04-16 |
The Regents Of The University Of California |
Non-invasive gene targeting to the brain
|
|
DE10109897A1
(de)
*
|
2001-02-21 |
2002-11-07 |
Novosom Ag |
Fakultativ kationische Liposomen und Verwendung dieser
|
|
ES2279127T3
(es)
*
|
2002-07-05 |
2007-08-16 |
Lipoxen Technologies Limited |
Procedimiento para aumentar una respuesta inmunitaria de vacunacion de acido nucleico.
|
|
DE10347710B4
(de)
|
2003-10-14 |
2006-03-30 |
Johannes-Gutenberg-Universität Mainz |
Rekombinante Impfstoffe und deren Verwendung
|
|
JP4546115B2
(ja)
*
|
2004-03-05 |
2010-09-15 |
三菱化学メディエンス株式会社 |
細胞中ａｔｐの定量法
|
|
DE102004057303A1
(de)
*
|
2004-11-26 |
2006-06-01 |
Merck Patent Gmbh |
Stabile Kristallmodifikationen von DOTAP Chlorid
|
|
DE102005046490A1
(de)
|
2005-09-28 |
2007-03-29 |
Johannes-Gutenberg-Universität Mainz |
Modifikationen von RNA, die zu einer erhöhten Transkriptstabilität und Translationseffizienz führen
|
|
CN100400667C
(zh)
*
|
2006-06-27 |
2008-07-09 |
浙江大学 |
脂质体包裹弓形虫pGRA4真核表达质粒的方法及用途
|
|
NZ578541A
(en)
|
2006-12-22 |
2012-04-27 |
Soluciones Biotecnologicas Innovacion Ltda |
Dna vaccines for fish
|
|
RU2367443C1
(ru)
*
|
2008-02-28 |
2009-09-20 |
Общество с ограниченной ответственностью "Битеп" |
Средство на основе природных фосфолипидов
|
|
EP2184054A1
(en)
|
2008-11-08 |
2010-05-12 |
Lipoxen Technologies Limited |
Small Interfering RNA Delivery
|
|
US9907746B2
(en)
|
2009-07-06 |
2018-03-06 |
Variation Biotechnologies, Inc. |
Methods for preparing vesicles and formulations produced therefrom
|
|
AU2010270722B2
(en)
*
|
2009-07-06 |
2015-06-04 |
Variation Biotechnologies, Inc. |
Methods for preparing vesicles and formulations produced therefrom
|
|
US10894098B2
(en)
|
2012-04-09 |
2021-01-19 |
Signablok, Inc. |
Methods and compositions for targeted imaging
|
|
US12419839B2
(en)
|
2009-10-09 |
2025-09-23 |
Signablok, Inc. |
Methods and compositions for targeted delivery of protein fragments
|
|
US10525152B2
(en)
|
2009-10-09 |
2020-01-07 |
Signablok, Inc. |
Methods and compositions for targeted imaging
|
|
HUE042177T2
(hu)
|
2009-12-01 |
2019-06-28 |
Translate Bio Inc |
Szteroidszármazék mRNS szállítására humán genetikai betegségekben
|
|
JP5902616B2
(ja)
*
|
2010-04-28 |
2016-04-13 |
協和発酵キリン株式会社 |
カチオン性脂質
|
|
MX342138B
(es)
|
2010-07-06 |
2016-09-14 |
Variation Biotechnologies Inc |
Composiciones y metodos para el tratamiento de influenza.
|
|
EP2590625B1
(en)
|
2010-07-06 |
2017-09-20 |
GlaxoSmithKline Biologicals SA |
Cationic oil-in-water emulsions
|
|
HUE026646T2
(en)
|
2010-07-06 |
2016-07-28 |
Glaxosmithkline Biologicals Sa |
Preferred liposomes containing lipids of PKA value for delivery of RNA
|
|
RS63817B1
(sr)
|
2010-07-06 |
2023-01-31 |
Glaxosmithkline Biologicals Sa |
Čestice za isporuku slične virionu za molekule samoreplicirajuće rnk
|
|
PL2591114T3
(pl)
|
2010-07-06 |
2017-08-31 |
Glaxosmithkline Biologicals Sa |
Immunizacja dużych ssaków małymi dawkami rna
|
|
HUE047796T2
(hu)
|
2010-07-06 |
2020-05-28 |
Glaxosmithkline Biologicals Sa |
RNS bevitele több immunútvonal bekapcsolására
|
|
PT3970742T
(pt)
|
2010-08-31 |
2022-06-27 |
Glaxosmithkline Biologicals Sa |
Lipossomas peguilados para entrega de arn codificador de imunogénio
|
|
JP2013544504A
(ja)
|
2010-10-11 |
2013-12-19 |
ノバルティス アーゲー |
抗原送達プラットフォーム
|
|
CA2862864C
(en)
|
2011-01-13 |
2018-12-11 |
Variation Biotechnologies Inc. |
Compositions and methods for treating viral infections
|
|
RU2491062C2
(ru)
*
|
2011-03-16 |
2013-08-27 |
Общество С Ограниченной Ответственностью "Биотехнологии Пущино" |
Композиции протекторов острых и хронических печеночных энцелопатий и способ лечения острых и хронических печеночных энцелопатий
|
|
HRP20211595T1
(hr)
|
2011-05-24 |
2022-01-21 |
BioNTech SE |
Individualizirana cjepiva protiv raka
|
|
PL3586861T3
(pl)
|
2011-06-08 |
2022-05-23 |
Translate Bio, Inc. |
Kompozycje nanocząstek lipidowych i sposoby dostarczania mrna
|
|
SG10201605512WA
(en)
|
2011-07-06 |
2016-09-29 |
Novartis Ag |
Oil-in-water emulsions that contain nucleic acids
|
|
WO2013006838A1
(en)
|
2011-07-06 |
2013-01-10 |
Novartis Ag |
Immunogenic combination compositions and uses thereof
|
|
CA2840965C
(en)
|
2011-07-06 |
2021-03-02 |
Novartis Ag |
Cationic oil-in-water emulsions
|
|
US20140356399A1
(en)
|
2012-01-12 |
2014-12-04 |
Variation Biotechnologies, Inc. |
Compositions and methods for treating viral infections
|
|
US20150079077A1
(en)
|
2012-01-27 |
2015-03-19 |
Variation Biotechnologies, Inc. |
Methods and compositions for therapeutic agents
|
|
WO2013143555A1
(en)
|
2012-03-26 |
2013-10-03 |
Biontech Ag |
Rna formulation for immunotherapy
|
|
EP3536787A1
(en)
|
2012-06-08 |
2019-09-11 |
Translate Bio, Inc. |
Nuclease resistant polynucleotides and uses thereof
|
|
US10245229B2
(en)
*
|
2012-06-08 |
2019-04-02 |
Translate Bio, Inc. |
Pulmonary delivery of mRNA to non-lung target cells
|
|
WO2014082729A1
(en)
|
2012-11-28 |
2014-06-05 |
Biontech Ag |
Individualized vaccines for cancer
|
|
PL3467108T3
(pl)
|
2013-03-14 |
2024-09-30 |
Translate Bio, Inc. |
Sposoby oczyszczania informacyjnego rna
|
|
KR20210122917A
(ko)
|
2013-03-14 |
2021-10-12 |
샤이어 휴먼 지네틱 테라피즈 인크. |
Cftr mrna 조성물 및 관련 방법 및 사용
|
|
WO2014180490A1
(en)
|
2013-05-10 |
2014-11-13 |
Biontech Ag |
Predicting immunogenicity of t cell epitopes
|
|
ES2707966T3
(es)
|
2013-10-22 |
2019-04-08 |
Translate Bio Inc |
Terapia de ARNm para la deficiencia en síntesis de argininosuccinato
|
|
EA034103B1
(ru)
|
2013-10-22 |
2019-12-27 |
Транслейт Био, Инк. |
СПОСОБ ЛЕЧЕНИЯ ФЕНИЛКЕТОНУРИИ С ПРИМЕНЕНИЕМ мРНК
|
|
EP3087193A4
(en)
*
|
2013-12-27 |
2017-08-09 |
Teloregen, Inc. |
Compositions and methods for providing active telomerase to cells in vivo
|
|
BR112016016356B1
(pt)
*
|
2014-01-17 |
2023-12-26 |
Fundació Institut Català De Nanociència I Nanotecnologia |
Lipossoma, usos dos mesmos, e composição farmacêutica ou veterinária
|
|
PT3134506T
(pt)
|
2014-04-25 |
2019-10-31 |
Translate Bio Inc |
Métodos de purificação de rna mensageiro
|
|
WO2016045732A1
(en)
|
2014-09-25 |
2016-03-31 |
Biontech Rna Pharmaceuticals Gmbh |
Stable formulations of lipids and liposomes
|
|
WO2016128060A1
(en)
|
2015-02-12 |
2016-08-18 |
Biontech Ag |
Predicting t cell epitopes useful for vaccination
|
|
WO2017059902A1
(en)
|
2015-10-07 |
2017-04-13 |
Biontech Rna Pharmaceuticals Gmbh |
3' utr sequences for stabilization of rna
|
|
EA201991747A1
(ru)
|
2017-02-27 |
2020-06-04 |
Транслейт Био, Инк. |
НОВАЯ КОДОН-ОПТИМИЗИРОВАННАЯ мРНК CFTR
|
|
MX2019013752A
(es)
|
2017-05-16 |
2020-07-20 |
Translate Bio Inc |
Tratamiento de la fibrosis quística mediante el suministro de arnm que codifica cftr optimizado en codones.
|
|
WO2018224166A1
(en)
|
2017-06-09 |
2018-12-13 |
Biontech Rna Pharmaceuticals Gmbh |
Methods for predicting the usefulness of disease specific amino acid modifications for immunotherapy
|
|
CA3108544A1
(en)
|
2018-08-24 |
2020-02-27 |
Translate Bio, Inc. |
Methods for purification of messenger rna
|
|
MX2021005969A
(es)
|
2018-11-21 |
2021-09-14 |
Translate Bio Inc |
Tratamiento de la fibrosis quística mediante el suministro de arnm que codifica cftr nebulizado.
|
|
EP3892260A1
(en)
*
|
2020-04-10 |
2021-10-13 |
Bayer Animal Health GmbH |
Immunostimulatory compositions based on liposomes with zwiterionic and cationic lipids
|
|
CA3210451A1
(en)
|
2021-03-22 |
2022-09-29 |
Illumina Cambridge Limited |
Methods for improving nucleic acid cluster clonality
|